BioHermes

Research focus

Head-to-head study of blood-based and digital AD biomarkers

Study type

Observational

Cohort type

Enrollment dates:

2021-2022

Location:

Multi-national

Partnerships & participating institutions:

AbbVie, ADDF, Aural Analytics, Biogen, C2N, Cognivue, EMTherapro, GV, GNS Healthcare, IXICO, Lilly, Linus, Merck, Pentara, Quanterix, Retispec, Roche, SomaLogic, Univ. of Gothenburg

Funding sources:

GAP

Publications:

N/A

Website:

Bio-Hermes – Global Alzheimer’s Platform Foundation (globalalzplatform.org)

Contact Us

Please contact info@neuroproteome.org with inquiries about joining the Global Neurodegeneration Proteomics Consortium (GNPC) or questions about accessing the resulting data.